Cite
MLA Citation
Johanna Bendell et al.. “388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A236. http://access.bl.uk/ark:/81055/vdc_100144717185.0x000003